XBiotech Inc

General ticker "XBIT" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $205.9M

XBiotech Inc follows the US Stock Market performance with the rate: 20.5%.

Estimated limits based on current volatility of 5.6%: low 4.20$, high 4.88$

Factors to consider:

  • Earnings for 6 months up through Q2 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [3.08$, 6.23$]
  • 2024-12-30 to 2025-12-30 estimated range: [3.04$, 6.11$]

Financial Metrics affecting the XBIT estimates:

  • Negative: Non-GAAP EPS, $ of -0.82 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
  • Negative: Operating cash flow per share per price, % of -13.12 <= 2.35
  • Negative: negative Net income
  • Positive: Interest expense per share, $ of 0 <= 0

Similar symbols

Short-term XBIT quotes

Long-term XBIT plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $18.39MM $4.01MM $0.00MM
Operating Expenses $43.48MM $38.50MM $37.51MM
Operating Income $-25.08MM $-34.49MM $-37.51MM
Non-Operating Income $-0.38MM $0.90MM $13.20MM
R&D Expense $28.27MM $31.54MM $32.85MM
Income(Loss) $-25.46MM $-33.59MM $-24.31MM
Taxes $-8.04MM $-0.69MM $0.24MM
Profit(Loss) $-17.41MM $-32.90MM $-24.56MM
Stockholders Equity $269.38MM $240.40MM $218.85MM
Inventory $8.95MM $0.00MM $0.00MM
Assets $275.18MM $246.10MM $226.62MM
Operating Cash Flow $69.44MM $-14.82MM $-18.73MM
Capital expenditure $3.52MM $0.58MM $0.36MM
Investing Cash Flow $-3.52MM $-63.89MM $61.50MM
Financing Cash Flow $-67.01MM $0.00MM $-0.01MM
Earnings Per Share* $-0.58 $-1.08 $-0.81

* EPS are Split Adjusted, recent splits may be reflected with a delay.